5′-Noraristeromycin possessing a C-1′ cyclopentyl double bond: A new carbanucleoside structural prototype

Tetrahedron

Volumn 60, Issue 15, 2004, Pages 3451-3455

  Yin, Xue Qiang ^a   Schneller, Stewart W ^a  

^a AUBURN UNIVERSITY   (United States)

Author keywords

Antiviral; Epoxide ring opening; Mitsunobu coupling; Neplanocin analogs

Indexed keywords

9 (3',4',5' TRIHYDROXYCYCLOPENT 1 ENYL)PURINE; ANTIVIRUS AGENT; NUCLEOSIDE DERIVATIVE; UNCLASSIFIED DRUG;

ANTIVIRAL ACTIVITY; ARTICLE; CARBON NUCLEAR MAGNETIC RESONANCE; CHEMICAL BOND; COLUMN CHROMATOGRAPHY; CONTROLLED STUDY; DAUDI CELL; DERIVATIZATION; DRUG STRUCTURE; DRUG SYNTHESIS; HOST CELL; HUMAN; HUMAN CELL; NONHUMAN; PRIORITY JOURNAL; PROTON NUCLEAR MAGNETIC RESONANCE;

EID: 1642410824     PISSN: 00404020     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.tet.2004.02.032     Document Type: Article

References (24)

1. Marquez V.E. Adv. Antiviral Drug Des. 2:1996;89-146.
2. Ferrero M., Gotor V. Chem. Rev. 100:2000;4319-4347.
3. Galeone A., Mayol L., Oliviero G., Piccialli G., Varra M. Tetrahedron. 58:2002;363-368.
4. Ravi R.G., Kim H.S., Servos J., Zimmermanm H., Lee K., Maddilefi S., Boyer J.L., Harden T.K., Jacobson K.A. J. Med. Chem. 45:2002;2090-2100.
5. For a leading reference, see Rajappan V.P., Schneller S.W., Williams S.L., Kern E.R. Bioorg. Med. Chem. 10:2002;883-886.
6. The cyclopentyl ring numbering convention for carbanucleosides employed in our long time investigations has designated the methylene, which has replaced the furanose oxygen of traditional nucleosides, as C-6′. As a consequence, compound 4 was granted the trivial 5′-noraristeromycin name as the parent structure. However, to avoid confusion with systematic cyclopentyl carbon numbering, the C-6′ designation is not utilized in describing the syntheses and experimental details herein.
7. Kitade Y., Kozacki A., Yatone C. Tetrahedron Lett. 42:2001;433-435.
8. Madhavan G.V.B., McGee D.P.C., Rydzewski R.M., Boehme R., Martin J.C., Prisbe E.J. J. Med. Chem. 31:1988;1798-1804. reported a small amount (3%) of (±)-i arising during the synthesis of a fluoroaristeromycin derivative.
9. (b) Similarly, a low yield of ii was described by Biggadike K., Borthwick A.D., Exall A.M. J. Chem. Soc., Chem. Commun. 1990;458-459. in their preparation of the pyrimidine analog of 2′-deoxyneplanocin A.
10. Bartsch R.A., Zavada J. Chem. Rev. 80:1980;453-492.
11. Yin X.-., Rajappan V.P., Roy A., Schneller S.W. Synth. Commun. 33:2003;1477-1481.
12. Yang N.C., Finnegan R.A. J. Am. Chem. Soc. 80:1958;5845-5848.
13. Neef G., Baesler S., Depke G., Vierhufe H. Tetrahedron Lett. 40:1999;7969-7973.
14. Structural assignments made after obtaining 13.
15. Gemal A.L., Luche J.L. J. Am. Chem. Soc. 103:1981;5454-5459.
16. Lim M.-I., Marquez V.E. Tetrahedron Lett. 24:1984;5559-5562.
17. Deardorff D.R., Shambayati S., Myles D.C., Heerding D. J. Org. Chem. 53:1988;3614-3615.
18. Song G.Y., Paul V., Choo H., Morrey J., Sidwell R.W., Schinazi R.F., Chu C.K. J. Med. Chem. 44:2001;3985-3993.
19. Wang P., Agrofoglio L.A., Newton M.G., Chu C.K. J. Org. Chem. 64:1999;4173-4176.
20. Song G.Y., Naguib F.N.M., el Kouni M.H., Chu C.K. Nucleosides Nucleotides Nucleic Acids. 20:2001;1915-1925.
21. Santana L., Teijeria M., Terán C., Uriarte E., Vida D. Synthesis. 2001;1532-1538.
22. -) and 2, human cytomegalovirus, varicella zoster virus, Epstein-Barr virus, vaccinia virus, cowpox virus, West Nile virus, Sindbis virus, adenovirus type 1, measles, Punta Toro virus, rhinovirus type 2, Venezuelan equine encephalitis, yellow fever, and HIV-1 and HIV-2. Compound 17 was also evaluated against coxsackie virus B4 and reovirus-1.
23. Seley K.L., Schneller S.W., Rattendi D., Lane S., Bacchi C.J. J. Med. Chem. 40:1997;625-629.
24. 13C signals were observed.